Market revenue in 2023 | USD 268.8 million |
Market revenue in 2030 | USD 488.4 million |
Growth rate | 8.9% (CAGR from 2023 to 2030) |
Largest segment | Therapeutics |
Fastest growing segment | Diagnostics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Diagnostics, Therapeutics |
Key market players worldwide | Roche, Siemens Healthineers AG ADR, Janssen Pharmaceuticals, Illumina Inc, Quest Diagnostics Inc, 23andMe Holding Co Class A, NeoDiagnostix, International Business Machines Corp, Myriad Genetics Inc, Medtronic PLC, GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Dakota Software, Biogen Inc, Qiagen NV, ImmunityBio Inc Ordinary Shares |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to precision medicine market will help companies and investors design strategic landscapes.
Therapeutics was the largest segment with a revenue share of 85.68% in 2023. Horizon Databook has segmented the UAE precision medicine market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.
Launched in early 2021, the Emirati Genome Program (EGP) aims to uncover profound genomics insights tailored to the Emirati population. As the UAE's inaugural national-scale population genomics initiative, the EGP holds promise for revolutionizing the management of local population health and wellness.
By offering personalized wellness and lifestyle recommendations, the program seeks to empower participating Emiratis to proactively address their health, leading to lifestyle changes and preventive measures supported by selected clinical tests.
A collaboration between the Ministry of Health and Prevention, the Department of Health Abu Dhabi, the Dubai Health Authority, and G42 Healthcare's subsidiary, G42 Healthcare Omics Center of Excellence, the EGP adheres to the highest ethical and governance standards, ensuring participant anonymity and data protection.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE precision medicine market , including forecasts for subscribers. This country databook contains high-level insights into UAE precision medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account